New Parkinson's drug Produodopa to be available on NHS –
– Nearly 1,000 people with advanced Parkinson's disease in the UK will benefit from the new treatment Produodopa, provided by NHS England.
– Produodopa utilizes a portable kit with a pump to administer medication continuously into the bloodstream, offering a consistent effect compared to traditional pill-based treatments.
Patients involved in clinical trials express positive experiences with the new treatment, citing improved symptom management and quality of life
Parkinson's UK acknowledges Produodopa as a potential "life-changing option" for some patients, emphasizing the importance of consulting healthcare professionals
– Many current Parkinson's patients rely on over 20 pills daily, facing inconsistent symptom control, which can worsen throughout the day and night.
NHS England's medical director for specialised services, James Palmer, highlights the significance of the drug's availability
Patients receive the infusion through a cannula under the skin, controlled by an automatic pump that releases medication 24 hours a day
– The treatment combines two drugs, foslevodopa and foscarbidopa, to convert into dopamine, aiding in symptom management such as excessive movement or tremors.